Carisma Therapeutics (CARM) - 2018 Q4 - Earnings Call Transcript
Carisma Therapeutics (CARM)2019-03-05 01:59
Sesen Bio, Inc. (NASDAQ:SESN) Q4 2018 Earnings Conference Call March 4, 2019 8:00 AM ET Company Participants Erin Clark - Executive Director, Strategic Planning & Investor Relations Thomas Cannell - President and Chief Executive Officer Dennis Kim - Chief Medical Officer Richard Fitzgerald - Chief Financial Officer Chad Myskiw - Head of Global CMC Project Management. Conference Call Participants John Newman - Canaccord Genuity Yale Jen - Laidlaw Capital Markets Swayampakula Ramakanth - H.C. Wainwright Chris ...